![Declan Doogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Declan Doogan
Direktor/Vorstandsmitglied bei
TENAX THERAPEUTICS, INC.
Vermögen: 33 087 $ am 30.06.2026
Profil
Dr. Declan Doogan, MD, ist ein unabhängiger Vorsitzender bei Biohaven Pharmaceutical Holding Co. Ltd, ein Chairman bei Portage Pharma Ltd, ein Independent Director bei Portage Biotech, Inc, ein Chairman bei Spinifex Pharmaceuticals Pty Ltd, ein Chairman bei Causeway Therapeutics Ltd, ein Chairman bei Celleron Therapeutics Ltd und ein Chairman bei iOX Therapeutics Ltd. Er ist Mitglied des Board of Directors von Tenax Therapeutics, Inc, Kleo Pharmaceuticals, Inc, Juvenescence Ltd, Portage Biotech, Inc, Intensity Therapeutics, Inc. und The Pulmonary Vascular Research Institute. Dr. Doogan war zuvor als Chief Medical Officer & Executive Vice President bei Prometheus Laboratories, Inc. beschäftigt, als Outside Director bei Sosei Group Corp., als Chief Medical Officer bei Amarin Corp. Plc, als Head-Worldwide Development bei Pfizer Inc., als Professor an der Harvard T.H. Chan School of Public Health, als Professor an der Kitasato University, als Senior Vice President-Head-Worldwide Development bei Pfizer (St. Louis), als Senior Vice President-Clinical R&D bei Pfizer Europe International Ltd, als Senior Vice President-Clinical R&D bei Pfizer Japan, Inc. und als Professor an der University of Glasgow School of Medicine. Er war auch im Vorstand von Heptares Therapeutics Ltd. Er erhielt seinen Doktortitel von der University of Glasgow und einen Doktortitel von der University of Kent.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TENAX THERAPEUTICS, INC. 0,01 % | 08.04.2026 | 2 274 ( 0,01 % ) | 33 087 $ | 30.06.2026 |
Aktive Positionen von Declan Doogan
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 25.02.2021 |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Direktor/Vorstandsmitglied | - |
Apterna Ltd. | Direktor/Vorstandsmitglied | - |
Mediqventures Ltd.
 Mediqventures Ltd. Finance/Rental/LeasingFinance Provides financing services for life science technologies | Corporate Officer/Principal | - |
BYOMass, Inc.
 BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses | Direktor/Vorstandsmitglied | 27.10.2021 |
Causeway Therapeutics Ltd.
 Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases | Vorsitzender | - |
Kleo Pharmaceuticals, Inc.
 Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Direktor/Vorstandsmitglied | 01.11.2019 |
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a global medical research charity | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Declan Doogan
| Unternehmen | Position | Ende |
|---|---|---|
| ALPHA COMPUTE CORP | Vorstandsvorsitzender | 06.05.2019 |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Declan Doogan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
29
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 29 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Tenax Therapeutics, Inc.
 Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Nxera Pharma Co., Ltd.
 Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
Pfizer Europe International Ltd.
 Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Topix Pharmaceuticals, Inc.
 Topix Pharmaceuticals, Inc. Household/Personal CareConsumer Non-Durables Manufactures and markets therapeutic and cosmetic skin care products | Consumer Non-Durables |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets medical drugs & vaccines | Commercial Services |
Kitasato University
 Kitasato University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a global medical research charity | Commercial Services |
University of Glasgow School of Medicine
 University of Glasgow School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
Mediqventures Ltd.
Mediqventures Ltd. Finance/Rental/LeasingFinance Provides financing services for life science technologies | Finance |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Commercial Services |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
BYOMass, Inc.
BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses | Commercial Services |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases | Health Technology |
Apterna Ltd. |
Wählen Sie MarketScreener 
